Pediatric Renovascular Hypertension: Diagnosis and Management

Area of Science:

• Pediatric Nephrology
• Cardiovascular Medicine
• Diagnostic Imaging

Background:

• Pediatric renovascular hypertension (RVH) is a key cause of secondary hypertension in children.
• Nonatherosclerotic etiologies like fibromuscular dysplasia (FMD) and mid-aortic syndrome (MAS) are common causes of renal artery stenosis (RAS).
• Early diagnosis is crucial to prevent renal dysfunction and cardiovascular disease.

Purpose of the Study:

• To review current diagnostic and therapeutic strategies for pediatric renovascular hypertension.
• To emphasize personalized care and the role of specialized centers in managing pediatric RVH.
• To highlight the importance of timely intervention for optimizing outcomes in affected children.

Main Methods:

• Review of current literature on pediatric renovascular hypertension diagnosis and management.
• Discussion of diagnostic modalities including ultrasound, CT angiography (CTA), MR angiography (MRA), and digital subtraction angiography (DSA).
• Exploration of therapeutic options ranging from pharmacological treatment to interventional procedures and surgery.

Main Results:

• Ultrasound is the initial diagnostic step, with advanced imaging like CTA, MRA, and DSA providing detailed assessments.
• Digital subtraction angiography (DSA) is considered the gold standard, often supplemented by intravascular pressure measurements and imaging.
• Percutaneous transluminal angioplasty is effective for many cases, while stenting and surgery are reserved for complex situations.

Conclusions:

• Multidisciplinary consensus and individualized treatment plans are essential for managing pediatric RVH.
• Pharmacological therapy alone is often insufficient; interventional procedures like angioplasty are frequently required.
• Specialized pediatric centers with expertise in RVH management are vital for achieving optimal patient outcomes.